Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the … TM Penning, ME Burczynski, JM Jez, CF Hung, HK Lin, H Ma, M Moore, ... Biochemical journal 351 (1), 67-77, 2000 | 790 | 2000 |
Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones TM Penning, ME Burczynski, CF Hung, KD McCoull, NT Palackal, ... Chemical research in toxicology 12 (1), 1-18, 1999 | 574 | 1999 |
Coronavirus vaccine development: from SARS and MERS to COVID-19 YD Li, WY Chi, JH Su, L Ferrall, CF Hung, TC Wu Journal of biomedical science 27, 1-23, 2020 | 569 | 2020 |
Prospects of RNA interference therapy for cancer SI Pai, YY Lin, B Macaes, A Meneshian, CF Hung, TC Wu Gene therapy 13 (6), 464-477, 2006 | 489 | 2006 |
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene CH Chen, TL Wang, CF Hung, Y Yang, RA Young, DM Pardoll, TC Wu Cancer research 60 (4), 1035-1042, 2000 | 484 | 2000 |
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen WF Cheng, CF Hung, CY Chai, KF Hsu, L He, M Ling, TC Wu The Journal of clinical investigation 108 (5), 669-678, 2001 | 359 | 2001 |
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype CL Trimble, S Piantadosi, P Gravitt, B Ronnett, E Pizer, A Elko, B Wilgus, ... Clinical cancer research 11 (13), 4717-4723, 2005 | 304 | 2005 |
DNA vaccine for cancer immunotherapy B Yang, J Jeang, A Yang, TC Wu, CF Hung Human vaccines & immunotherapeutics 10 (11), 3153-3164, 2014 | 287 | 2014 |
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer A Monie, CF Hung, R Roden, TC Wu Biologics: Targets and Therapy 2 (1), 107-113, 2008 | 271 | 2008 |
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden ML Stone, KB Chiappinelli, H Li, LM Murphy, ME Travers, MJ Topper, ... Proceedings of the National Academy of Sciences 114 (51), E10981-E10990, 2017 | 270 | 2017 |
Antigen‐specific immunotherapy of cervical and ovarian cancer CF Hung, TC Wu, A Monie, R Roden Immunological reviews 222 (1), 43-69, 2008 | 256 | 2008 |
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe C Trimble, CT Lin, CF Hung, S Pai, J Juang, L He, M Gillison, D Pardoll, ... Vaccine 21 (25-26), 4036-4042, 2003 | 249 | 2003 |
Therapeutic human papillomavirus vaccines: current clinical trials and future directions CF Hung, B Ma, A Monie, SW Tsen, TC Wu Expert opinion on biological therapy 8 (4), 421-439, 2008 | 245 | 2008 |
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus TW Kim, JH Lee, CF Hung, S Peng, R Roden, MC Wang, R Viscidi, ... Journal of virology 78 (9), 4638-4645, 2004 | 244 | 2004 |
Perspectives for therapeutic HPV vaccine development A Yang, E Farmer, TC Wu, CF Hung Journal of biomedical science 23, 1-19, 2016 | 238 | 2016 |
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins TW Kim, CF Hung, M Ling, J Juang, L He, JM Hardwick, S Kumar, TC Wu The Journal of clinical investigation 112 (1), 109-117, 2003 | 236 | 2003 |
Cervical cancer immunotherapy: facts and hopes L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu Clinical Cancer Research 27 (18), 4953-4973, 2021 | 233 | 2021 |
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression AD Bins, A Jorritsma, MC Wolkers, CF Hung, TC Wu, TNM Schumacher, ... Nature medicine 11 (8), 899-904, 2005 | 231 | 2005 |
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7 … H Ji, TL Wang, CH Chen, SI Pai, CF Hung, KY Lin, RJ Kurman, ... Human gene therapy 10 (17), 2727-2740, 1999 | 230 | 1999 |
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen WF Cheng, CF Hung, CY Chai, KF Hsu, L He, M Ling, TC Wu Journal of virology 75 (5), 2368-2376, 2001 | 213 | 2001 |